Gerard Drewes

Gerard Drewes

Auto-generated profile, based on publicly available information

Gerard Drewes

Cellzome GmbH, Molecular Discovery Research, GlaxoSmithKline, Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2002 in Nature
Verified
Journal Article
Closed access
PDF file
AGAnne-Claude Gavin
Anne-Claude Gavin
MBMarkus Bösche
Markus Bösche
RKRoland Krause
Roland Krause
PGPaola Grandi
Paola Grandi
MMMartina Marzioch
Martina Marzioch
GSGiulio Superti-Furga
Giulio Superti-Furga

22 January 2006 in Nature
Verified
Journal Article
Closed access
PDF file
AGAnne-Claude Gavin
Anne-Claude Gavin
PAPatrick Aloy
Patrick Aloy
PGPaola Grandi
Paola Grandi
RKRoland Krause
Roland Krause
MBMarkus Boesche
Markus Boesche
GSGiulio Superti-Furga
Giulio Superti-Furga

2 October 2011 in Nature
Verified
Journal Article
Closed access
PDF file
MDMark A. Dawson
Mark A. Dawson
RPRab K. Prinjha
Rab K. Prinjha
ADAntje Dittmann
Antje Dittmann
GGGeorge Giotopoulos
George Giotopoulos
MBMarcus Bantscheff
Marcus Bantscheff
TKTony Kouzarides
Tony Kouzarides

3 October 2014 in Science
Verified
Journal Article
Closed access
PDF file
MSMikhail M. Savitski
Mikhail M. Savitski
FRFriedrich B. M. Reinhard
Friedrich B. M. Reinhard
HFHolger Franken
Holger Franken
TWThilo Werner
Thilo Werner
MSMaria Fälth Savitski
Maria Fälth Savitski
GDGerard Drewes
Gerard Drewes
Mapping human drug targets in the cell: To understand both the beneficial and the side effects of a drug, one would need to know its full binding profile to all cellular proteins. Savitskiet al.take significant steps toward meeting this daunting challenge. They monitored the unfolding or “melting” of over 7000 human proteins and measured how small-molecule binding changes individual melting profiles. As a proof of principle, over 50 targets were identified for an inhibitor known to bind a broad spectrum of kinases. Two cancer drugs, vemurafib and Alectinib, are known to have a side effect of photosensitivity. The thermal profiling approach identified drug-protein interactions responsible for these side effects.Science, this issue10.1126/science.1255784

26 August 2007 in Nature Biotechnology
Verified
Journal Article
Closed access
MBMarcus Bantscheff
Marcus Bantscheff
DEDirk Eberhard
Dirk Eberhard
YAYann Abraham
Yann Abraham
SBSonja Bastuck
Sonja Bastuck
MBMarkus Boesche
Markus Boesche
GDGerard Drewes
Gerard Drewes

25 January 2004 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
TBTewis Bouwmeester
Tewis Bouwmeester
ABAngela Bauch
Angela Bauch
HRHeinz Ruffner
Heinz Ruffner
PAPierre-Olivier Angrand
Pierre-Olivier Angrand
GBGiovanna Bergamini
Giovanna Bergamini
GSGiulio Superti-Furga
Giulio Superti-Furga